Partnership in Cancer Research (PCAR)

癌症研究合作伙伴 (PCAR)

基本信息

  • 批准号:
    10222627
  • 负责人:
  • 金额:
    $ 15.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Partnership in Cancer Research (PCAR) seeks to provide first and second-year medical students an innovative hands-on cancer research experience in a laboratory, clinical, or community setting. The PCAR experience will serve a class of 12 participants for 10 weeks during the summer. The research experience will be enriched by team-based learning on the molecular and cell biology of cancer alongside clinical simulations and experiences of cancer screening, treatment, and palliation. The overarching goal of the cancer research experiences is to spark the participants’ interest in future careers as cancer clinical specialists and researchers. The program will enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. Individual cancer research projects are where the students spend most of their time. The research will be put into context with weekly active learning sessions on the biology of cancer. Clinical experiences will expose participants to current issues in the treatment and ongoing care of people with cancer; this aspect will also give participants insight into how basic and community-engaged science affect clinical practice and how clinical problems can be turned into research questions. The entrepreneurship program features teams of 3 participants independently proposing marketable cancer research solutions through weekly sessions with entrepreneur mentors. The aims are to: 1) Provide individual medical students an outstanding hands-on experience in cancer research. Students will perform research with one of about 50 different faculty members performing cancer research in basic science, clinical research, or community engaged research. Throughout the course, teams of participants will integrate their research experiences and ideas in the online and in-person mentored “Cure Cancer Entrepreneurship program” . 2) Provide context for participants’ research with team-based learning and clinical exposures. Weekly team-based learning sessions will engage students in learning detailed information on molecular and cellular biology of cancer, as well as principles of community based medicine. Clinical exposure includes hands-on medical simulations of cancer related topics, social media interaction with a moderated patient support group, and a visit to the palliative care clinic that will take up no more than 2 hours per week. 3) Determine program outcomes through rigorous evaluation. Pre and post testing will be used to determine students gain in cancer research knowledge. Surveys will be used to evaluate all aspects of the course content, faculty, and activities. Long term tracking of participants and similar sized cohort of medical students who did not participate in PCAR will be used to investigate efficacy in influencing career choice in cancer research.
癌症研究伙伴关系(PCAR)旨在为一年级和二年级的医学生提供一个

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS JOSEPH KELLY其他文献

THOMAS JOSEPH KELLY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS JOSEPH KELLY', 18)}}的其他基金

Partnership in Cancer Research (PCAR)
癌症研究合作伙伴 (PCAR)
  • 批准号:
    10676820
  • 财政年份:
    2020
  • 资助金额:
    $ 15.6万
  • 项目类别:
Partnership in Cancer Research (PCAR)
癌症研究合作伙伴 (PCAR)
  • 批准号:
    10470140
  • 财政年份:
    2020
  • 资助金额:
    $ 15.6万
  • 项目类别:
Partnership in Cancer Research (PCAR)
癌症研究合作伙伴 (PCAR)
  • 批准号:
    10024400
  • 财政年份:
    2020
  • 资助金额:
    $ 15.6万
  • 项目类别:
MEMBRANE PROTEASES INVOLVED IN TRANSFORMED CELL INVASION
参与转化细胞侵袭的膜蛋白酶
  • 批准号:
    3034063
  • 财政年份:
    1991
  • 资助金额:
    $ 15.6万
  • 项目类别:
MEMBRANE PROTEASES INVOLVED IN TRANSFORMED CELL INVASION
参与转化细胞侵袭的膜蛋白酶
  • 批准号:
    3034060
  • 财政年份:
    1990
  • 资助金额:
    $ 15.6万
  • 项目类别:
MEMBRANE PROTEASES INVOLVED IN TRANSFORMED CELL INVASION
参与转化细胞侵袭的膜蛋白酶
  • 批准号:
    3034062
  • 财政年份:
    1990
  • 资助金额:
    $ 15.6万
  • 项目类别:
STUDENT PARTNERS IN CANCER RESEARCH AND EDUCATION
癌症研究和教育的学生合作伙伴
  • 批准号:
    6766739
  • 财政年份:
    1989
  • 资助金额:
    $ 15.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了